{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:49Z","timestamp":1787163889793,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:00:00Z","timestamp":1676764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.brachy.2023.02.004","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T09:38:29Z","timestamp":1679391509000},"page":"416-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8111-3896","authenticated-orcid":false,"given":"Paul T.","family":"Finger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Beers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7484-4068","authenticated-orcid":false,"given":"Jacob","family":"Kamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly J.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Mohney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby S.","family":"Welles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-5913","authenticated-orcid":false,"given":"Wolfgang A.G.","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2023.02.004_bib0001","first-page":"373","article-title":"Malignant melanoma of the choroid treated with radioactive applicators","volume":"79","author":"Stallard","year":"1959","journal-title":"Trans Ophthalmol Soc UK"},{"issue":"2","key":"10.1016\/j.brachy.2023.02.004_bib0002","first-page":"140","article-title":"The role of radiotherapy in the treatment of pterygium: a review of the literature including more than 6000 treated lesions","volume":"15","author":"Ali","year":"2011","journal-title":"Cancer Radiother J Soc Francaise Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0003","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-2008-1051007","article-title":"A beta ray applicator (106Ru\/106Rh) in the treatment of ciliary body melanomas","volume":"187","author":"Ballin","year":"1985","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.brachy.2023.02.004_bib0004","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0167-8140(90)90203-9","article-title":"Conjunctival intraepithelial and invasive squamous cell carcinomas treated with strontium-90","volume":"17","author":"Cerezo","year":"1990","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0005","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of I-125 and Pd-103 COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.02.004_sbref0006","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/349162","article-title":"The use of strontium-90 Beta radiotherapy as adjuvant treatment for conjunctival melanoma","volume":"2013","author":"Cohen","year":"2013","journal-title":"J Oncol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0007","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1055\/a-1391-9110","article-title":"Brachytherapy for peripheral retinal capillary haemangioblastoma in von Hippel-Lindau disease","volume":"238","author":"Dalbah","year":"2021","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.brachy.2023.02.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161674","article-title":"Is beta radiation better than 5 flurouracil as an adjunct for trabeculectomy surgery when combined with cataract surgery? A randomised controlled trial","volume":"11","author":"Dhalla","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.brachy.2023.02.004_bib0009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0002-9394(79)90196-X","article-title":"The use of strontium-90 in the treatment of carcinoma in situ of the conjunctiva","volume":"87","author":"Elkon","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0010","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/bjo.87.12.1497","article-title":"Palladium-103 plaque radiation therapy for macular degeneration: results of a 7-year study","volume":"87","author":"Finger","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s004170050038","article-title":"Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration","volume":"236","author":"Jaakkola","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.brachy.2023.02.004_bib0012","article-title":"Beta radiation for glaucoma surgery","volume":"13","author":"Kirwan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.brachy.2023.02.004_bib0013","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00407844","article-title":"beta-Ray treatment of malignant epibulbar melanoma","volume":"209","author":"Lommatzsch","year":"1978","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol Albrecht Von Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.brachy.2023.02.004_bib0014","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bjo.75.10.584","article-title":"Trabeculectomy combined with beta irradiation for congenital glaucoma","volume":"75","author":"Miller","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s004170050059","article-title":"Results of treatment of choroidal malignant melanoma with high-dose-rate strontium-90 brachytherapy. A retrospective study of 46 patients treated between 1983 and 1995","volume":"236","author":"Missotten","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0016","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2011.11.002","article-title":"Ruthenium-106 plaque therapy (RPT) for retinoblastoma","volume":"84","author":"Murakami","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.brachy.2023.02.004_bib0017","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/IAE.0000000000001616","article-title":"Ruthenium-106 brachytherapy in the treatment of circumscribed choroidal hemangioma","volume":"38","author":"Naseripour","year":"2018","journal-title":"Retina Phila Pa"},{"key":"10.1016\/j.brachy.2023.02.004_bib0018","first-page":"147","article-title":"Ophthalmic radiotherapy: plaques and implants","volume":"1","author":"Finger","year":"2019"},{"key":"10.1016\/j.brachy.2023.02.004_bib0019","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/ICB.0b013e31823c12a3","article-title":"Epimacular brachytherapy for the treatment of retinal angiomatous proliferation","volume":"6","author":"Petrarca","year":"2012","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.brachy.2023.02.004_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.17116\/oftalma201513125-11","article-title":"Plaque radiotherapy for anterior uveal melanomas","volume":"131","author":"Saakyan","year":"2015","journal-title":"Vestn Oftalmol"},{"issue":"1","key":"10.1016\/j.brachy.2023.02.004_bib0021","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000088259","article-title":"Beta-ray brachytherapy of retinoblastoma: feasibility of a new small-sized ruthenium-106 plaque","volume":"38","author":"Schueler","year":"2006","journal-title":"Ophthalmic Res"},{"issue":"10","key":"10.1016\/j.brachy.2023.02.004_bib0022","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bjo.2005.068460","article-title":"18-years\u2019 experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma","volume":"89","author":"van Ginderdeuren","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.brachy.2023.02.004_bib0023","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(97)00088-X","article-title":"Radiation therapy for choroidal melanoma","volume":"42","author":"Finger","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.02.004_bib0025","first-page":"135","article-title":"Radiotherapy of choroidal melanoma with iodine-125","volume":"20","author":"Packer","year":"1980","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.brachy.2023.02.004_bib0026","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0161-6420(80)35194-4","article-title":"Radiotherapy of choroidal melanoma with iodine-125","volume":"87","author":"Packer","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2023.02.004_bib0027","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/archopht.1991.01080110148053","article-title":"Palladium-103 ophthalmic plaque radiotherapy","volume":"109","author":"Finger","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0028","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s13566-014-0149-4","article-title":"Pd-103 versus I-125 ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomas","volume":"3","author":"Finger","year":"2014","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0029","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brachy.2008.05.002","article-title":"The impact of prescription depth, dose rate, plaque size, and source loading on the central axis using 103Pd, 125I, and 131Cs","volume":"7","author":"Rivard","year":"2008","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.02.004_bib0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0002-9394(76)90731-5","article-title":"Beta-ray treatment of malignant epithelial tumors of the conjunctiva","volume":"81","author":"Lommatzsch","year":"1976","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0031","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.70.11.844","article-title":"Results after beta-irradiation (106Ru\/106Rh) of choroidal melanomas: 20 years\u2019 experience","volume":"70","author":"Lommatzsch","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0032","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5114\/jcb.2014.55003","article-title":"Superficial ocular malignancies treated with strontium-90 brachytherapy: long term outcomes","volume":"7","author":"Laskar","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2023.02.004_bib0033","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5114\/jcb.2021.106191","article-title":"Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis","volume":"13","author":"Karimi","year":"2021","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2023.02.004_bib0034","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/bjo.74.10.615","article-title":"Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva","volume":"74","author":"Lommatzsch","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1463-5224.2007.00489.x","article-title":"Combined keratectomy, strontium-90 irradiation and permanent bulbar conjunctival grafts for corneolimbal squamous cell carcinomas in horses (1990-2002): 38 horses","volume":"10","author":"Plummer","year":"2007","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0036","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.ijrobp.2006.02.002","article-title":"Beta-ray brachytherapy with 106Ru plaques for retinoblastoma","volume":"65","author":"Schueler","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.brachy.2023.02.004_bib0037","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/bjophthalmol-2014-306327","article-title":"The treatment of carcinoma in situ and squamous cell carcinoma of the conjunctiva with fractionated strontium-90 radiation in a population with a high prevalence of HIV","volume":"99","author":"Lecuona","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0038","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatol"},{"issue":"2","key":"10.1016\/j.brachy.2023.02.004_bib0039","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-022-05956-w","article-title":"Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group","volume":"50","author":"Salem","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2023.02.004_bib0040","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.clgc.2022.05.006","article-title":"A phase 1 study of selective internal radiation therapy using yttrium-90 resin microspheres in patients with primary renal cell carcinoma","volume":"20","author":"de Souza","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"10.1016\/j.brachy.2023.02.004_bib0041","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1097\/HP.0b013e31826566f0","article-title":"Long-lived impurities of 90Y-labeled microspheres, TheraSphere and SIR-spheres, and the impact on patient dose and waste management","volume":"103","author":"Metyko","year":"2012","journal-title":"Health Phys"},{"issue":"2","key":"10.1016\/j.brachy.2023.02.004_bib0042","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00270-019-02366-8","article-title":"Predictors of overall and progression-free survival in patients with ocular melanoma metastatic to the liver undergoing Y-90 radioembolization","volume":"43","author":"Levey","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0043","doi-asserted-by":"crossref","first-page":"266","DOI":"10.21037\/jgo.2016.11.08","article-title":"Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma","volume":"8","author":"Wang","year":"2017","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"10.1016\/j.brachy.2023.02.004_bib0044","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1007\/s00417-022-05736-0","article-title":"Two-year outcomes of episcleral brachytherapy adjunct to anti-VEGF therapy for treatment-resistant nAMD","volume":"260","author":"Chhablani","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0045","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/bjo.82.7.763","article-title":"Correlation between Octopus perimetry and fluorescein angiography after strontium-90 plaque brachytherapy for subfoveal exudative age-related macular degeneration","volume":"82","author":"Jaakkola","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0046","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/ijo.IJO_707_19","article-title":"Radiation therapy for exudative choroidal hemangioma","volume":"67","author":"Finger","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0047","first-page":"114","article-title":"[Capillary hemangioma of the retina in cases of von Hippel-Lindau syndrome. New therapeutic directions]","volume":"104","author":"Bornfeld","year":"2007","journal-title":"Ophthalmol Z Dtsch Ophthalmol Ges"},{"key":"10.1016\/j.brachy.2023.02.004_bib0048","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijrobp.2012.07.2352","article-title":"Radiation therapy for neovascular age-related macular degeneration","volume":"85","author":"Kishan","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.02.004_bib0049","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bmj.38971.395301.7C","article-title":"Effect of beta radiation on success of glaucoma drainage surgery in South Africa: randomised controlled trial","volume":"333","author":"Kirwan","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.brachy.2023.02.004_bib0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1590\/S0004-27492011000400016","article-title":"Meta-analysis of beta radiation augmentation for trabeculectomy - results in distinct ethnic groups","volume":"74","author":"de Fendi","year":"2011","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0051","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ijrobp.2008.02.075","article-title":"Long-term results and prognostic factors of fractionated strontium-90 eye applicator for pterygium","volume":"72","author":"Viani","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.02.004_bib0052","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ijrobp.2010.07.1983","article-title":"Comparative study of different \u03b2-radiation doses for preventing pterygium recurrence","volume":"81","author":"Yamada","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.brachy.2023.02.004_bib0053","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3928\/15428877-20110603-03","article-title":"High-frequency ultrasound measurements of the normal ciliary body and iris","volume":"42","author":"Garcia","year":"2011","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.brachy.2023.02.004_bib0054","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archopht.125.8.1051","article-title":"High-frequency ultrasound characteristics of 24 iris and iridociliary melanomas: before and after plaque brachytherapy","volume":"125","author":"Finger","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.brachy.2023.02.004_bib0055","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ophtha.2017.02.015","article-title":"Regression patterns of iris melanoma after palladium-103 (103Pd) plaque brachytherapy","volume":"124","author":"Chaugule","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2023.02.004_bib0056","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archopht.121.2.168","article-title":"High frequency ultrasonographic evaluation of conjunctival intraepithelial neoplasia and squamous cell carcinoma","volume":"121","author":"Finger","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0057","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/archopht.1995.01100110122037","article-title":"Ultrasound biomicroscopy in the management of malignant melanoma of the iris","volume":"113","author":"Katz","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0058","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archophthalmol.2011.286","article-title":"Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study","volume":"130","author":"Khan","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0059","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ophtha.2017.11.040","article-title":"Iris melanoma outcomes based on the American Joint Committee on Cancer Classification (eighth edition) in 432 patients","volume":"125","author":"Shields","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2023.02.004_bib0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajo.2019.01.031","article-title":"The Small Fatal Choroidal Melanoma Study. A survey by the European Ophthalmic Oncology Group","volume":"202","author":"Jouhi","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0061","unstructured":"FDA. FDA Clearance Statement. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/K193602.pdf Accessed date March 13th, 2023."},{"key":"10.1016\/j.brachy.2023.02.004_bib0062","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1118\/1.4951734","article-title":"Guidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: report of Task Group 167","volume":"43","author":"Nath","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.02.004_bib0063","doi-asserted-by":"crossref","first-page":"227","DOI":"10.6028\/jres.108.030","article-title":"New national air-kerma-strength standards for 125I and 103Pd brachytherapy seeds","volume":"108","author":"Seltzer","year":"2003","journal-title":"J Res Nat Stand Technol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0064","doi-asserted-by":"crossref","DOI":"10.1118\/1.4861715","article-title":"Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom","volume":"41","author":"Lesperance","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.02.004_bib0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1118\/1.3523614","article-title":"Comparison of dose calculation methods for brachytherapy of intraocular tumors","volume":"38","author":"Rivard","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.02.004_bib0066","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1118\/1.3679010","article-title":"BEDVH-A method for evaluating biologically effective dose volume histograms: application to eye plaque brachytherapy implants","volume":"39","author":"Gagne","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.02.004_bib0067","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1118\/1.4718683","article-title":"Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function","volume":"39","author":"Gagne","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.02.004_bib0068","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1167\/iovs.03-0151","article-title":"Dose fractionation effects in primary and metastatic human uveal melanoma cell lines","volume":"44","author":"van den Aardweg","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.brachy.2023.02.004_bib0069","unstructured":"J\u00e4rvinen H, Cross W, Soares C, Vynckier S, Weaver K. Dosimetry of beta rays and low-energy photons for brachytherapy with sealed sources. International Commission of Radiological Units and Measurements Report 72. Available at:https:\/\/www.icru.org\/report\/dosimetry-of-beta-rays-and-low-energy-photons-for-brachytherapy-with-sealed-sources-report-72\/ Accessed date March 13th, 2023."},{"key":"10.1016\/j.brachy.2023.02.004_bib0070","first-page":"e172","article-title":"Dosimetry of beta-emitting brachytherapy sources for age-related macular degeneration","volume":"45","author":"Rivard","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.02.004_bib0071","first-page":"L13","article-title":"Modernizing NuDat using the latest computing technologies to facilitate nuclear physics research","volume":"2022","author":"Mason","year":"2022","journal-title":"APS April Meet Abstr"},{"key":"10.1016\/j.brachy.2023.02.004_bib0072","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/archopht.126.4.531","article-title":"Finger's amniotic membrane buffer technique: protecting the cornea during radiation plaque therapy","volume":"126","author":"Finger","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0073","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1177\/1120672120914235","article-title":"Palladium-103 plaque therapy for multifocal iris melanoma: Radiation of the entire anterior segment of the eye","volume":"31","author":"Finger","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.brachy.2023.02.004_bib0074","first-page":"469","article-title":"Beta radiation therapy in ophthalmology","volume":"50","author":"Hughes","year":"1952","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:19:12Z","timestamp":1761531552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472123000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1538472123000247"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.02.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}